Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2024) 144 (Supplement 1): 3030.

https://doi.org/10.1182/blood-2024-198992

Published: 2024

Journal Articles

BV-CHP in Previously Untreated Patients with CD30-Positive Adult T-Cell Leukemia-Lymphoma: A Multicenter Real-World Retrospective Study

Junya Makiyama, Masahito Tokunaga, Motoaki Shiratsuchi, Takanori Toyama, Satoshi Oka, Ilseung Choi, Takahiro Yoshida, Kiyoshi Okazuka, Atae Utsunomiya

Blood (2024) 144 (Supplement 1): 4435.

https://doi.org/10.1182/blood-2024-204218

Published: 2024

Journal Articles

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2023) 142 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2023-174647

Published: 2023

Journal Articles

PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL

Blood (2023) 142 (Supplement 1): 3074.

https://doi.org/10.1182/blood-2023-184933

Published: 2023

Journal Articles

CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma

Kazuki Tanimoto, Koji Kato, Takatoshi Aoki, Goichi Yoshimoto, Ilseung Choi, Masanori Kadowaki, Yasuhiro Sugio, Takuro Kuriyama, Noriaki Kawano, Ritsuro Suzuki, Kohta Miyawaki, Hideho Henzan, Noriyuki Saito, Takanori Ohta, Toshihiro Miyamoto, Koichi Akashi

Blood (2021) 138 (Supplement 1): 1393.

https://doi.org/10.1182/blood-2021-151937

Published: 2021

Journal Articles

Yittrium 90 Ibritumomab Tiuxetan (Zevalin®) in the Treatment of Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma; Integrated Analysis of Three Japanese Institution's Experience with Improvement Trend of the Long-Term Responses over a 10 Year Study Period

Ilseung Choi, MD, Masaya Okada, MD, Tomoki Ito, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138386

Published: 2020

Journal Articles

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Hiroyuki Muranushi, MD, Takero Shindo, MD PhD, Masakatsu Hishizawa, MD PhD, Masahito Tokunaga, MD PhD, Atsushi Wake, MD PhD, Nobuaki Nakano, MD, Tetsuya Eto, MD PhD, Michihiro Hidaka, MD PhD, Ilseung Choi, MD PhD, Toshihiro Miyamoto, MD PhD, Naoyuki Uchida, MD PhD, Yukiyoshi Moriuchi, MD, Yasuhiko Miyazaki, MD PhD, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Koji Kato, MD PhD

Blood (2019) 134 (Supplement_1): 2008.

https://doi.org/10.1182/blood-2019-123318

Published: 2019

Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Blood (2018) 132 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2018-99-114850

Published: 2018

Journal Articles

Phase II Trial of CH5424802 (alectinib hydrochloride) for Recurrent or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Masahiro Sekimizu, MD PhD, Reiji Fukano, MD PhD, Ilseung Choi, MD PhD, Akiko Kada, PhD, Akiko Saito, MD, Ryuta Asada, PhD, Tetsuya Mori, MD PhD, Hirokazu Nagai, MD PhD

Blood (2018) 132 (Supplement 1): 2924.

https://doi.org/10.1182/blood-2018-99-112708

Published: 2018

Journal Articles

Phase 1/2 Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Venetoclax in Japanese Subjects with Chronic Lymphocytic Leukemia

Kiyohiko Hatake, MD PhD, Kazuhito Yamamoto, MDPhD, Noriko Fukuhara, MD PhD, Shigeru Kusumoto, MD, Koji Izutsu, MD, PhD, Ilseung Choi, MD, Hirokazu Nagai, MD PhD, Hideyuki Honda, BS, Junjiro Saeki, MS, Andrew W. Roberts, MS, Paulo Maciag, MD PhD, Suresh Agarwal, MS, PhD RPh, Ahmed Hamed Salem, PhD, Kevin J. Freise, PhD, Tsukasa Kiriyama, PharmD, BSc, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 5352.

https://doi.org/10.1182/blood.V130.Suppl_1.5352.5352

Published: 2017

Journal Articles

Oral HDAC Inhibitor HBI8000 in Japanese Patients with Non-Hodgkin Lymphoma (NHL): Phase I Safety and Efficacy Results

Makoto Onizuka, MD PhD, Kiyoshi Ando, MD PhD, Makoto Yoshimitsu, MD, PhD, Takashi Ishida, MD PhD, S Yoshida, MD, Ilseung Choi, MD, Michihiro Hidaka, MD, Yasushi Takamatsu, MD PhD, Midori Nagashima, Akira Miyazato, MD PhD, Joachim P Schupp, MD, Alain Rolland, PharmD, PhD, Mireille Gillings, PhD, Gloria T. Lee, MD PhD, Kensei Tobinai, MD PhD

Blood (2016) 128 (22): 1827.

https://doi.org/10.1182/blood.V128.22.1827.1827

Published: 2016

Journal Articles

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

Junichi Kiyasu, Hiroaki Miyoshi, Akie Hirata, Fumiko Arakawa, Ayako Ichikawa, Daisuke Niino, Yasuo Sugita, Yuji Yufu, Ilseung Choi, Yasunobu Abe, Naokuni Uike, Koji Nagafuji, Takashi Okamura, Koichi Akashi, Ryoichi Takayanagi, Motoaki Shiratsuchi, Koichi Ohshima

Blood (2015) 126 (19): 2193–2201.

https://doi.org/10.1182/blood-2015-02-629600

Published: 2015

Includes: Supplemental data

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

Ryuji Tanosaki, MD PhD, Ilseung Choi, MD, Mototsugu Shimokawa, PhD, Atae Utsunomiya, MD PhD, Masahito Tokunaga, MD, Nobuaki Nakano, MD, Takahiro Fukuda, MD, Hirohisa Nakamae, Shigeki Takemoto, MD PhD, Shigeru Kusumoto, MD PhD, Takeaki Tomoyose, Eisaburo Sueoka, MD PhD, Motoaki Shiratsuchi, Youko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike

Blood (2014) 124 (21): 2580.

https://doi.org/10.1182/blood.V124.21.2580.2580

Published: 2014

Journal Articles

A Multicenter Phase I Study of the Humanized Anti-CD19 Monoclonal Antibody, MEDI-551, in Patients with Relapsed or Refractory B-Cell Lymphoma and Multiple Myeloma

Michinori Ogura, MD PhD, Kiyoshi Ando, MD, Naokuni Uike, Yoshiaki Ogawa, MD, Toshiki Uchida, MD, Yasunobu Abe, MD, Takanobu Morishita, MD, Minoru Kojima, MD PhD, Ilseung Choi, MD, Katsuro Yagawa, MD, Yuki Yokoi, Jun Okamura, MD

Blood (2014) 124 (21): 1756.

https://doi.org/10.1182/blood.V124.21.1756.1756

Published: 2014

Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 2641.

https://doi.org/10.1182/blood.V120.21.2641.2641

Published: 2012

Journal Articles

Multicenter Phase I Dose-Escalation Study of Lenalidomide in Patients with Relapsed Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL).

Naokuni Uike, MD, PhD, Michinora Ogura, Yoshitaka Imaizumi, MD, PhD, Norio Asou, MD, PhD, Atae Utsunomiya, MD, PhD, Toshiki Uchida, Tomohiro Aoki, Kunihiro Tsukasaki, MD, PhD, Jun Taguchi, MD, Ilseung Choi, MD, Dai Maruyama, MD, PhD, Kisato Nosaka, MD, PhD, Nianhang Chen, Ph D, Tetsuhiro Shiota, Kensei Tobinai, MD, PhD

Blood (2012) 120 (21): 2737.

https://doi.org/10.1182/blood.V120.21.2737.2737

Published: 2012

Journal Articles

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Tetsuya Eto, MD, Ilseung Choi, MD, Ryuji Tanosaki, MD, Yoshifusa Takatsuka, MD, Atae Utsunomiya, MD, Shigeki Takemoto, MD, PhD, Jun Taguchi, MD, Takuya Fukushima, MD, Koji Kato, MD, PhD, Takanori Teshima, MD, PhD, Yoko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike, MD, PhD

Blood (2011) 118 (21): 4163.

https://doi.org/10.1182/blood.V118.21.4163.4163

Published: 2011

Journal Articles

Durable Responses with Bendamustine Monotherapy In Patients with Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle-Cell Lymphoma (MCL): Updated Follow-up Data From a Japanese Multicenter Phase II Study

Kuniaki Itoh, MD, PhD, Kiyoshi Ando, MD, PhD, Michinori Ogura, MD, PhD, Kenichi Ishizawa, MD, PhD, Takashi Watanabe, MD, PhD, Naokuni Uike, MD, PhD, Yasuhito Terui, MD, PhD, Kensuke Usuki, MD, PhD, Hirokazu Nagai, MD, PhD, Nobuhiko Uoshima, MD, PhD, Nobuko Kubota, MD, PhD, Ken Ohmachi, MD, PhD, Toshiki Uchida, MD, PhD, Joji Yamamoto, MD, PhD, Ilseung Choi, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2010) 116 (21): 4884.

https://doi.org/10.1182/blood.V116.21.4884.4884

Published: 2010

Journal Articles

Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia: The Results of a Second Multi-Center Prospective Study and the Impact of Antithymocyte Globulin on Early Relapse.

Naokuni Uike, MD, Ryuji Tanosaki, M.D., Atae Utsunomiya, M.D., Ilseung Choi, M.D., Masato Masuda, M.D., Yoshio Saburi, M.D., Masao Tomonaga, M.D., Tetsuya Etoh, M.D., Michihiro Hidaka, M.D., Mari Kannagi, M.D., Mine Harada, M.D., Jun Okamura, M.D.

Blood (2006) 108 (11): 5359.

https://doi.org/10.1182/blood.V108.11.5359.5359

Published: 2006

Journal Articles

Target Dose Adjustment of Oral Busulfan Using a Test Dose in Japanese Adults Undergoing Hematopoietic Stem Cell Transplantation.

Yasushi Takamatsu, MD, Kentaro Ogata, PhD, Noriaki Sasaki, PhD, Shuuji Hara, PhD, Tetsuya Eto, MD, Kouji Kato, MD, Kouji Nagafuji, MD, Yasunobu Abe, MD, Akira Kubota, MD, Ilseung Choi, MD, Rie Imamura, MD, Yutaka Imamura, MD, Naoya Taira, MD, Junji Suzumiya, MD, Kazuo Tamura, MD

Blood (2005) 106 (11): 5313.

https://doi.org/10.1182/blood.V106.11.5313.5313

Published: 2005

NARROW

Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan

BV-CHP in Previously Untreated Patients with CD30-Positive Adult T-Cell Leukemia-Lymphoma: A Multicenter Real-World Retrospective Study

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL

CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma

Yittrium 90 Ibritumomab Tiuxetan (Zevalin®) in the Treatment of Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma; Integrated Analysis of Three Japanese Institution's Experience with Improvement Trend of the Long-Term Responses over a 10 Year Study Period

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Phase II Trial of CH5424802 (alectinib hydrochloride) for Recurrent or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Phase 1/2 Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Venetoclax in Japanese Subjects with Chronic Lymphocytic Leukemia

Oral HDAC Inhibitor HBI8000 in Japanese Patients with Non-Hodgkin Lymphoma (NHL): Phase I Safety and Efficacy Results

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

A Multicenter Phase I Study of the Humanized Anti-CD19 Monoclonal Antibody, MEDI-551, in Patients with Relapsed or Refractory B-Cell Lymphoma and Multiple Myeloma

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Multicenter Phase I Dose-Escalation Study of Lenalidomide in Patients with Relapsed Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL).

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Durable Responses with Bendamustine Monotherapy In Patients with Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle-Cell Lymphoma (MCL): Updated Follow-up Data From a Japanese Multicenter Phase II Study

Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia: The Results of a Second Multi-Center Prospective Study and the Impact of Antithymocyte Globulin on Early Relapse.

Target Dose Adjustment of Oral Busulfan Using a Test Dose in Japanese Adults Undergoing Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only